Last reviewed · How we verify

Nasal Povidone Iodine

VA Office of Research and Development · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

Nasal Povidone Iodine is a Small molecule drug developed by VA Office of Research and Development. It is currently FDA-approved. Also known as: Povidone Iodine.

Povidone Iodine Nasal Irrigation is being studied as a potential treatment for conditions such as Chronic Rhinosinusitis and COVID-19, according to ClinicalTrials.gov. The exact mechanism of action of Povidone Iodine is unknown, as per ChEMBL.

At a glance

Generic nameNasal Povidone Iodine
Also known asPovidone Iodine
SponsorVA Office of Research and Development
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Nasal Povidone Iodine

What is Nasal Povidone Iodine?

Nasal Povidone Iodine is a Small molecule drug developed by VA Office of Research and Development.

Who makes Nasal Povidone Iodine?

Nasal Povidone Iodine is developed and marketed by VA Office of Research and Development (see full VA Office of Research and Development pipeline at /company/va-office-of-research-and-development).

Is Nasal Povidone Iodine also known as anything else?

Nasal Povidone Iodine is also known as Povidone Iodine.

What development phase is Nasal Povidone Iodine in?

Nasal Povidone Iodine is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing